Search

everythinglearnresearchcommunity

for

Search:↓

A woman's temporary hair loss was caused by high prolactin levels from her medication.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

The conclusion is that hirsutism is strongly linked to PCOS and higher levels of certain hormones, but not to DHEAS, prolactin, cortisol, or TSH.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Mouflon rams mature gradually with changes in body, horns, and hormones linked to age and seasons, reaching full sexual maturity well after puberty.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.

Melatonin implants affect the growth and pattern of cashmere goat fleece depending on the time of year they are given.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

A boy's early puberty caused by a testicular tumor returned to normal after surgery.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Low-dose spironolactone is safe and effective for treating hirsutism.

Women with acne often have higher levels of male hormones and are more likely to be overweight, both of which can make acne worse.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

Melatonin increases cashmere quality in goats but reduces their milk production and doesn't affect their offspring's hair growth.

Excessive androgen in women can cause acne, hair growth, baldness, and PCOS, often treatable with medication.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Ficus carica extract improved fertility in rats and may help with certain health conditions.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.